The esophagoscopes and gastroscopes market has seen considerable growth due to a variety of factors.
• In recent times, the market size of esophagoscopes and gastroscopes has seen substantial growth. The predicted growth is from $1.67 billion in 2024 to $1.78 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%.
The historical growth in this market is associated with the prevalence of gastrointestinal issues, early diagnosis and cancer screening, minimally invasive procedures and an increasingly aging population.
The esophagoscopes and gastroscopes market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market for esophagoscopes and gastroscopes is projected to experience substantial growth. It is expected to increase to $2.3 billion in 2029, with a compound annual growth rate (CAGR) of 6.6%.
This projected growth can be credited to factors such as the expansion of outpatient endoscopy centers, a surge in patient preference for non-invasive procedures, advancements in imaging and visualization techniques, and the growth of healthcare infrastructure. Key trends during this forecast period include advancements in endoscopy technology, technological innovation, 3d imaging, and the application of artificial intelligence (AI) in image analysis.
An increase in the prevalence of inflammatory bowel disease is a significant factor contributing to the growth of the esophagoscope and gastroscope market. This chronic disease results in inflammation in the digestive tract which can effectively be diagnosed and managed using esophagoscopes and gastroscopes, as these medical instruments allow for the detailed examination and study of the gastrointestinal tract. For example, a research article from March 2023 in the Journal of the Canadian Association of Gastroenterology - an open-access peer-reviewed journal based in Canada - projected the incidence rate of inflammatory bowel disease in Canada to rise from 825 per 100,000 population in 2023, to 1075 per 100,000 population in 2035. As such, this spike in inflammatory bowel disease cases is fueling the demand and growth for esophagoscopes and gastroscopes.
The esophagoscopes and gastroscopes market covered in this report is segmented –
1) By Type: Rigid, Flexible, Transnasal, Other Types
2) By Application: Gastroesophageal Reflux Disease, Ulcers, Barrett's Esophagus, Celiac Disease, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Rigid: Rigid Esophagoscopes, Rigid Gastroscopes
2) By Flexible: Flexible Esophagoscopes, Flexible Gastroscopes
3) By Transnasal: Transnasal Esophagoscopes, Transnasal Gastroscopes
4) By Other Types: Single-Use Endoscopes, Dual-Use Endoscopes
In the esophagoscopes and gastroscopes market, principal companies are concentrating on creating inventive solutions such as flexible endoscopes for a competitive edge. A flexible endoscope, a medical device used to examine internal parts like the gastrointestinal tract, employs a bendable tube equipped with a camera, delivering real-time images and facilitating minimally invasive procedures. For example, Lumicell, a biotech firm based in the US, was awarded a $400,000 Phase I Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) in October 2024. They plan to use this grant to develop an innovative flexible endoscope to diagnose Barrett's esophagus. The imaging platform of this endoscope will merge far infrared fluorescence and reflected light imaging to detect real-time likely cancerous lesions. This could significantly aid earlier detection of esophageal adenocarcinoma (EAC). Presently, the diagnosis of precancerous lesions depends on endoscopy and random biopsies, a process that's not always efficient or swift. Through this technology, Lumicell aspires to augment sensitivity of diagnosis, decrease resource reliance, and enable immediate treatment of the detected lesions.
Major companies operating in the esophagoscopes and gastroscopes market are:
• Medtronic PLC
• FUJIFILM Corporation
• Stryker Corporation
• Boston Scientific Corporation
• B Braun Melsungen AG
• Olympus Corporation
• HOYA Corporation
• Smith & Nephew PLC
• Ethicon Inc.
• Hologic Inc.
• Steris PLC
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• CONMED Corporation
• Ambu A/S
• Richard Wolf GmbH
• SonoScape Medical Corporation
• Vimex Endoscopy Sp. z o.o.
• Smart Medical Systems Ltd.
• Jedmed Instrument Co
• Endomed Systems GmbH
• Maxer Endoscopy GmbH
• Surtex Instruments Limited
• FENTEX medical GmbH
• Machida Endoscope Co. Ltd.
• Aohua Endoscopy Co. Ltd.
• Zhejiang Shendasiao Medical Instrument Co. Ltd.
• Hangzhou Orient Medical Co. Ltd.
• Medical Device Depot Inc.
• Optec Endoscopy Systems GmbH.
North America was the largest region in the esophagoscopes and gastroscopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophagoscopes and gastroscopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.